W Ted Love
Affiliations
- at Structure Therapeutics Inc. (GPCR), 2025-06-25
- Director at Royalty Pharma Plc (RPRX), 2025-05-14
- Director at Gilead Sciences Inc. (GILD), 2025-05-08
- at Seagen Inc. (SGEN), 2023-12-15
- President And Ceo at Global Blood Therapeutics Inc. (GBT), 2022-10-06
- Director at Portola Pharmaceuticals Inc (PTLA), 2020-07-02
- Director at Amicus Therapeutics Inc. (FOLD), 2020-06-08
- Director at Cascadian Therapeutics Inc. (CASC), 2018-03-13
- Director at Kalobios Pharmaceuticals Inc (KBIO), 2015-07-14
- Director at Santarus Inc (SNTS), 2014-01-06
- Director at Mast Therapeutics Inc. (MSTX), 2013-06-21
- Evp, R&D And Tech. Operations at Onyx Pharmaceuticals Inc (ONXX), 2012-07-28
- Director at Affymax Inc (AFFY), 2012-06-18
- Director at Bio Rad Laboratories Inc (BIO, BIO.B), 2010-03-25
- Director at Arca Biopharma Inc. (ABIO), 2010-02-09
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| CASC | $4.24 | 23,000 | $97,520.00 | 27,209 | 2017-02-02 | Filing |
| GBT | $20.00 | 2,500 | $50,000.00 | 2,500 | 2015-08-17 | Filing |
| GBT | $20.00 | 2,500 | $50,000.00 | 2,500 | 2015-08-17 | Filing |
| GBT | $20.00 | 5,000 | $100,000.00 | 1,140,711 | 2015-08-17 | Filing |
| SNTS | $10.88 | 185,000 | $2,012,800.00 | 335,500 | 2012-12-18 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| GBT | $80.00 | 40,000 | $3,200,160.00 | 1,034,633 | 2020-04-28 | Filing |
| GBT | $80.63 | 1,517 | $122,319.81 | 1,074,633 | 2020-04-27 | Filing |
| GBT | $81.15 | 1,300 | $105,493.96 | 1,076,150 | 2020-04-27 | Filing |
| GBT | $70.92 | 1,818 | $128,939.65 | 1,077,450 | 2020-02-18 | Filing |
| GBT | $70.22 | 2,189 | $153,720.77 | 1,079,268 | 2020-02-18 | Filing |